Insmed D&A increased by 7.4% to $2.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.8%, from $1.26M to $2.08M. Over 4 years (FY 2021 to FY 2025), D&A shows a downward trend with a -9.9% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2015
Last reportedQ1 2026
How to read this metric
Higher levels often indicate significant recent capital investment or large historical acquisitions, while lower levels may suggest aging assets.
Detailed definition
Depreciation and amortization represent the systematic allocation of the cost of tangible and intangible assets over the...
Peer comparison
High in capital-intensive industries like healthcare and manufacturing; peers often report this as a significant non-cash drag on earnings.
Metric ID:
depreciation_and_amortizationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26M | $1.26M | $5.31M | $1.26M | $1.26M | $1.26M | $1.51M | $1.26M | $1.26M | $1.26M | $1.71M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.54M | $1.94M | $2.08M |
| QoQ Change | — | +0.1% | +320.1% | -76.2% | +0.0% | +0.0% | +19.6% | -16.4% | +0.0% | +0.0% | +35.5% | -26.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +21.8% | +25.9% | +7.4% |
| YoY Change | — | — | — | — | +0.0% | -0.1% | -71.5% | +0.0% | +0.0% | +0.0% | +13.2% | +0.0% | +0.0% | +0.0% | -26.2% | +0.0% | +0.0% | +21.8% | +53.4% | +64.8% |
Range$1.26M – $5.31M
CAGR+11.1%
Avg YoY Growth+3.5%
Median YoY Growth+0.0%
Current Streak8 quarters growth
Product Breakdown
| Segment | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|
| PARI milestones | $50.50K | $50.50K | $50.50K |
| Total | $1.26M | $1.26M | $1.26M |
Business Segments
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M |
| Total | $1.51M | $1.26M | $1.26M | $1.26M | $1.71M | $1.26M | $1.26M | $1.26M |
D&A at Other Companies
Frequently Asked Questions
- What is Insmed's d&a?
- Insmed (INSM) reported d&a of $2.08M in Q1 2026.
- How has Insmed's d&a changed year-over-year?
- Insmed's d&a increased by 64.8% year-over-year, from $1.26M to $2.08M.
- What is the long-term trend for Insmed's d&a?
- Over 4 years (2021 to 2025), Insmed's d&a has grown at a -9.9% compound annual growth rate (CAGR), from $9.10M to $6.00M.
- What does d&a mean?
- The non-cash expense that spreads the cost of physical and intangible assets over their useful life.